Kanya Rajangam - Net Worth and Insider Trading

Kanya Rajangam Net Worth

The estimated net worth of Kanya Rajangam is at least $0 dollars as of 2024-05-10. Kanya Rajangam is the Chief Medical Officer of Nkarta Inc and owns about 0 shares of Nkarta Inc (NKTX) stock worth over $0. Details can be seen in Kanya Rajangam's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kanya Rajangam has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).

Transaction Summary of Kanya Rajangam

To

Kanya Rajangam Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kanya Rajangam owns 3 companies in total, including Nkarta Inc (NKTX) , Senti Biosciences Inc (SNTI) , and Turnstone Biologics Corp (TSBX) .

Click here to see the complete history of Kanya Rajangam’s form 4 insider trades.

Insider Ownership Summary of Kanya Rajangam

Ticker Comapny Transaction Date Type of Owner
NKTX Nkarta Inc 2021-08-05 Chief Medical Officer
SNTI Senti Biosciences Inc 2022-07-05 Chief Medical & Devt. Officer
TSBX Turnstone Biologics Corp 2023-07-20 director

Kanya Rajangam Latest Holdings Summary

Kanya Rajangam currently owns a total of 1 stock. Kanya Rajangam owns 0 shares of Nkarta Inc (NKTX) as of August 5, 2021, with a value of $0.

Latest Holdings of Kanya Rajangam

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NKTX Nkarta Inc 2021-08-05 0 6.30 0

Holding Weightings of Kanya Rajangam


Kanya Rajangam Form 4 Trading Tracker

According to the SEC Form 4 filings, Kanya Rajangam has made a total of 1 transactions in Nkarta Inc (NKTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nkarta Inc is the sale of 10,000 shares on August 5, 2021, which brought Kanya Rajangam around $372,800.

Insider Trading History of Kanya Rajangam

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kanya Rajangam Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kanya Rajangam Ownership Network

Ownership Network List of Kanya Rajangam

No Data

Ownership Network Relation of Kanya Rajangam


Kanya Rajangam Owned Company Details

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Kanya Rajangam is the Chief Medical Officer of Nkarta Inc. Other key executives at Nkarta Inc include 10 percent owner Ra Capital Healthcare Fund Lp , Chief Scientific Officer James Trager , and Chief Medical Officer David Shook .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Kanya Rajangam made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nkarta Inc Insider Transactions

No Available Data

Kanya Rajangam Mailing Address

Above is the net worth, insider trading, and ownership report for Kanya Rajangam. You might contact Kanya Rajangam via mailing address: C/o Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco Ca 94080.

Discussions on Kanya Rajangam

No discussions yet.